Health Condition 1: L509- Urticaria, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients clinically diagnosed with chronic urticaria. 2.Participants of any gender, including male, female, and transgender individuals, will be eligible for the study. 3.Patients belonging to the age group 18 years to 65 years. 4.Literate patients who can read English or Hindi will be included. 5.Illiterate patients will also be enrolled, and investigators will assist them in completing the questionnaires or scales while ensuring adequate privacy. 6.Participants who will provide informed consent, comply with the study protocols, and attend all scheduled follow-up visits.
Exclusion criteria
Exclusion criteria: 1.Patients suffering from severe systemic illnesses or any other life-threatening conditions. 2.Patients with a history of severe anaphylactic shock. 3.Pregnant and lactating women. 4.Patients who refuse to give informed consent and not willing to come for follow ups.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatmentTimepoint: 12 weeks to 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the changes in the quality of life of patients suffering from chronic urticaria using Chronic Urticaria Quality of Life Questionnaire(CU-Q2oL)Timepoint: 12 weeks to 24 weeks | — |
Countries
India
Contacts
State National Homoeopathic Medical College and Hospital